PubRank

Andrew H Lichtman

Author PubWeight™ 55.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 2005 2.95
2 Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003 2.91
3 Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 2006 2.73
4 Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013 2.37
5 In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003 2.12
6 Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. Cell Metab 2012 1.90
7 T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A 2005 1.82
8 Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006 1.77
9 Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003 1.69
10 Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011 1.47
11 IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 2012 1.44
12 Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 2009 1.40
13 Influence of C3 deficiency on atherosclerosis. Circulation 2002 1.37
14 Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation 2007 1.37
15 T-cell costimulation and coinhibition in atherosclerosis. Circ Res 2008 1.32
16 IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest 2003 1.31
17 T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity. J Immunol 2006 1.31
18 B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2004 1.30
19 CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ Res 2008 1.26
20 PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. J Immunol 2012 1.24
21 Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. J Clin Invest 2010 1.23
22 Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 2011 1.20
23 Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest 2007 1.19
24 BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Exp Med 2005 1.16
25 The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol 2013 1.13
26 Difference in Th1 and Th17 lymphocyte adhesion to endothelium. J Immunol 2012 1.04
27 Protecting the pump: controlling myocardial inflammatory responses. Annu Rev Physiol 2006 1.02
28 Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol 2011 1.02
29 Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am J Pathol 2003 0.98
30 Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J Immunol 2012 0.98
31 Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J Immunol 2011 0.94
32 The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol 2007 0.93
33 Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection. Circulation 2011 0.87
34 Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart. J Immunol 2006 0.84
35 Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis. Trends Cardiovasc Med 2004 0.84
36 The link between IFN-gamma and allograft arteriopathy: is the answer NO? J Clin Invest 2004 0.82
37 Beta-galactoside alpha2,3-sialyltransferase-I gene expression during Th2 but not Th1 differentiation: implications for core2-glycan formation on cell surface proteins. Eur J Immunol 2002 0.81
38 T cells and blood vessels: costimulation turns up the pressure. Circulation 2010 0.80
39 Why don't macrophages leave atherosclerotic lesions? Circ Res 2012 0.77
40 Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread. J Clin Oncol 2012 0.77
41 Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males. Metabolism 2012 0.77
42 Targeting interferon-gamma to treat atherosclerosis. Circ Res 2007 0.76
43 Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis. Circulation 2013 0.76
44 Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr) 2012 0.75